Previous studies have already established AP’s ability to arrest liver-stage development in the rodent malaria model, P.

USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...

X™ T-Cell Transduction Sponge is honored in the Lab Research Tools category of the 2025 Top Innovations contest.

Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

Systemic lupus erythematosus is a clinically and immunologically heterogenous, systemic autoimmune disease characterized by ...

A research team led by Prof. HAN Shuo from the Center for Excellence in Molecular Cell Science of the Chinese Academy of Sciences developed a novel cell-surface protein engineering strategy called ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. The manuscript ...

Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a business update and provides its final audited financial results ...

Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, Orsay, France Therapeutic antibodies have revolutionized the treatment of many diseases. However, their safety and ...